Atypical parkinsonism combining α-synuclein inclusions and polyglucosan body disease

Movement Disorders

Volumn 20, Issue 2, 2005, Pages 200-204

  Krim, Elsa ^a   Vital, Anne ^a   Macia, Frederic ^a   Yekhlef, Farid ^a   Tison, François ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Synuclein inclusions; Adult polyglucosan body disease; Multiple system atrophy; Parkinsonism

Indexed keywords

ALPHA SYNUCLEIN; CARBIDOPA; LEVODOPA; PERGOLIDE;

ADULT POLYGLUCOSAN BODY DISEASE; AGED; ARTICLE; CASE REPORT; CELL INCLUSION; CEREBELLUM; DISEASE ASSOCIATION; DRUG RESPONSE; HISTOPATHOLOGY; HUMAN; MALE; NEUROLOGIC DISEASE; OLIGODENDROGLIA; PARKINSONISM; PONS; PRIORITY JOURNAL; PUTAMEN; SHY DRAGER SYNDROME; SYNCOPE; URINE INCONTINENCE;

AGED; ALPHA-SYNUCLEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCANS; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; LEWY BODIES; MALE; MULTIPLE SYSTEM ATROPHY; NERVE TISSUE PROTEINS; PARKINSONIAN DISORDERS; REVIEW LITERATURE; STAINING AND LABELING; SYNUCLEINS;

EID: 14944357361     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20285     Document Type: Article

References (36)

1. Susuki K, David E, Kutschman B. Presenile dementia with "Lafora-like" intraneuronal inclusions. Arch Neurol 1971; 25:69-80.
2. Robitaille Y, Carpenter S, Karpati G, et al. A distinct form of polyglucosan disease with massive involvement of central and peripheral neuronal process and astrocytes. Brain 1980;103:316-336.
3. Lossos A, Meiner Z, Barash U, et al. Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr 329 Ser mutation in the glycogen-branching enzyme gene. Ann Neurol 1998;44:867-872.
4. Sindern E, Patzold T, Vorgerd N, et al. Adult polyglucosan body disease. Case report with predominant involvement of central and peripheral nervous system and branching enzyme defect in leucocytes. Nervenartz 1999;70:745-749.
5. Ziemssen F, Sindern E, Schroder JM, et al. Novel mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease. Ann Neurol 2000;47:536-540.
6. Sindern E, Ziemssen F, Ziemssen T, et al. Adult polyglucosan body disease. A post-mortem correlation study. Neurology 2003; 61:263-265.
7. Gilman S, Low P, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
8. Bruno C, Servidei S, Shanoke S, et al. Glycogen branching enzyme deficiency in adult polyglucosan disease. Ann Neurol 1993;33:88-93.
9. Mc Donald TD, Faust PL, Bruno C, et al. Polyglucosan body disease simulating amyotrophic lateral sclerosis. Neurology 1993; 43:785-790.
10. Boulan-Predseil P, Vital A, Brochet B, et al. Dementia of frontal lobe type due to adult polyglucosan disease. J Neurol 1995;242: 512-516.
11. Rifai Z, Klitzke M, Tawil R, et al. Dementia of adult polyglucosan body disease. Evidence of cortical and subcortical dysfunction. Arch Neurol 1994;51:90-94.
12. Robertson N, Wharton S, Anderson J, et al. Adult polyglucosan body disease associated with extrapyramidal syndrome. J Neurol Neurosurg Psychiatry 1998;65:788-790.
13. Trivedi JR, Wolfe GI, Nations SP, et al. Adult polyglucosan body disease associated with Lewy bodies and tremor. Arch Neurol 2003;60:764-766.
14. Cafferty M, Lovelace R, Hays A, et al. Polyglucosan body disease. Muscle Nerve 1991;14:102-107.
15. Chretien F, Gray F. Polyglucosan body disease. Arch Anat Cytol Pathol 1993;41:9-17.
16. Vital A, Lamarche J, Bernier JP, et al. Significance of polyglucosan bodies in neuropathology. Clinicopathologic study of 7 cases. Ann Pathol 1995;15:269-275.
17. Postler E, Sindern E, Vorgerd M, et al. Fatal cardiomyopathy in adult polyglucosan body disease. Pathology 2002;23:229-234.
18. Cavanagh JB. Corpora-amylacea and the family of polyglucosan diseases. Brain Res Rev 1999;29:265-295.
19. Leel-ossy L. New data on the ultrastructure of the corpus amylaceum (polyglucosan body). Pathol Oncol Res 2001;7:145-150.
20. Milde P, Guccien JG, Kelly J, et al. Adult polyglucosan body disease. Arch Pathol Lab Med 2001;125:519-522.
21. Bigio EH, Weiner MF, Bonte FJ, et al. Familial dementia due to adult polyglucosan body disease. Clin Neuropathol 1997;16:227-234.
22. Klein CM, Bosch EP, Dyck PJ. Probable adult polyglucosan body disease. Mayo Clin Proc 2000;75:1327-1331.
23. Carpenter S, Karpam GG. Intraaxonal polyglucosan bodies: an unusual lesion of peripheral nerve. Neurology 1976;26:369.
24. Peress NS, Dimauro S, Roxburgh V. Adult polysaccharidosis: clinicopathological, ultrastructural and biochemical features. Arch Neurol 1982;36:840-845.
25. Stam FC, Wigboldus JM, Bots AN. Presenile dementia. A form of Lafora disease. J Am Geriatr Soc 1980;28:237-240.
26. Okamoto K, Liena JF, Hirano A. Type of adult polyglucosan body disease. Acta Neuropathol 1982;58:73-77.
27. Vos AJM, Joosten EMG, Gabreels-Festen AWH. Adult polyglucosan body disease: clinical and nerve biopsy findings in two cases. Ann Neurol 1983;13:440-443.
28. Karpati G, Carpenter S. The clinical spectrum of adult polyglucosan body disease. Neurology 1983;33:246.
29. Taboada E, Suzuki K, Traugott U, et al. Adult polyglucosan inclusion body disease. Int Congress Neuropathol Exp Neurol 1986;45:366.
30. Gray F, Gherardi R, Marshall A, et al. Adult polyglucosan body disease. J Neuropathol Exp Neurol 1988;47:459-474.
31. Wisniewski T, Goldman J, Resor L. Dementia associated with polyglucosan bodies. Neurology 1990;40(Suppl.):338.
32. Sugiyama H, Hainfellner JA, Lassman H, et al. Uncommon types of polyglucosan bodies in the human brain: distribution and relation to diseases. Acta Neuropathol 1993;86:484-490.
33. Matsumuro K, Izumo S, Minauchi Y, et al. Chronic demyelinating neuropathy and intraaxonal polyglucosan bodies. Acta Neuropathol 1993;86:95-99.
34. Wierzba-Bodrowicz T, Stroinska-Kus B. Adult polyglucosan body disease. Folia Neuropathol 1994;32:37-41.
35. Berkhoff M, Weis J, Schreth G. Extensive white-matter changes in case of adult polyglucosan body disease. Neuroradiology 2001;43: 234-236.
36. Wenning GK, Quinn N, Magalhaes M, Mathias C, Daniel S. "Minimal change" multiple system atrophy. Mov Disord 1994; 9:161-166.